Biogen (BIIB) has announced that Maria Freire will become the chair of its board of directors following the 2026 annual meeting, succeeding Caroline Dorsa who is retiring. Freire has been a board member since 2021. The announcement highlights Biogen’s financial health, noting mixed revenue growth but strong profitability, while its valuation metrics show the stock near historical highs.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Biogen (BIIB) Appoints Maria Freire as Upcoming Chair of Board
Biogen (BIIB) has announced that Maria Freire will become the chair of its board of directors following the 2026 annual meeting, succeeding Caroline Dorsa who is retiring. Freire has been a board member since 2021. The announcement highlights Biogen’s financial health, noting mixed revenue growth but strong profitability, while its valuation metrics show the stock near historical highs.